Stocks in Play - December 15th 2025

Stocks in Play: More Biotechs…

Welcome to today's Stocks in Play report. Below are the key stocks to watch, along with brief x-ray and analysis.

If you find this Newsletter helpful and ever want to say thank you then feel free to Buy Me a Coffee. It’ll inspire me to work faster….

Today’s Picks

Very rushed newsletter this morning as I had a ton of Internet issues this morning. Even though I have two connections in case one fails! Both were down!

Biotechs: 

MIST - FDA Approval on new Nasal Spray Product. First in 30 Years. Needs over $3.

KYTX - Very strong Phase 2 Data.

IMNM Very strong Phase 3 Data. Stock is not exactly neglected but if it can push over $25 it can really go.

X-Ray MIST: Industry Group: Biotechnology, Market Cap: 205.26M, Float: 81.02M Short Interest 9.12%, Days to Cover: 2.80, Exchange: NASDAQ

X-Ray KYTX: Industry Group: Biotechnology, Market Cap: 384.53M, Float: 21.91M Short Interest 16.11%, Days to Cover: 5.02, Exchange: NASDAQ

X-Ray IMNM: Industry Group: Biotechnology, Market Cap: 1.79B, Float: 89.23M Short Interest 17.11%, Days to Cover: 10.58, Exchange: NASDAQ

That’s it for today! Sorry for the short nature and lateness!

Delayed Reaction Watchlist (click here Tradingview)

Sources & Services I Use in my Trading:

• Finviz - Short Interest, Float, Articles, Fundamentals (Free)

• Benzinga Pro - News Source + News Squawk + Earnings Data (Paid)

• Tradingview - Charting & Scanning (Paid)

• BiopharmaIQ - FDA Calendars & Upcoming Catalysts (Paid)

• Koyfin - Fundamental Data (Paid)

• EarningsWhispers - Earnings Calendar (Free)

• Tradersync - Trade Journal (Paid)

_{PS: There are many ways to trade stocks in play. It does not have to be the one that keeps going straight up and sometimes it doesn’t even have to be day one of the catalyst. Everyone must find a setup, timeframe and method that works for them. This list is supposed to educate on the criteria I use and the methods in which I find Stocks in Play. Yours may differ and that is completely okay.}